Sepsis Prediction by Monocyte Distribution Width and Procalcitonin
- Conditions
- Diagnoses DiseaseSepsis
- Interventions
- Diagnostic Test: Monocyte Distribution Width
- Registration Number
- NCT04322942
- Lead Sponsor
- Chang Gung Memorial Hospital
- Brief Summary
The mortality rate of sepsis remains as high as 30 to 40%. Early diagnosis and treatment of patients with sepsis reduce mortality significantly. The most commonly used biomarkers in clinical practice are C-reactive protein (CRP) and procalcitonin (PCT). In terms of exploring new diagnostic tools of sepsis, monocyte distribution width (MDW) was first reported in 2017. It was reported as part of the white blood cell (WBC) differential count. MDW greater than 20 and abnormal WBC count together were reported to provide a satisfactory accuracy. The area under curve (AUC) in predicting sepsis-2 is 0.852. It was proposed as a novel diagnostic tool of sepsis in the emergency setting. Nonetheless, the performance of MDW compared with the conventional biomarkers remained unknown. The aim of this study was to compare the diagnostic accuracy of MDW and PCT on sepsis in the emergency department.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 600
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Sepsis-3 Monocyte Distribution Width - Non-infection Monocyte Distribution Width - Infection without sepsis Monocyte Distribution Width - Sepsis-2 Monocyte Distribution Width -
- Primary Outcome Measures
Name Time Method Sensitivity and specificity of predicting sepsis and sepsis-3 patients within 2 hours after patient arrived ED. MDW, PCT, and other laboratory tests were all obtained at the same time with 2 hours after the patient was admitted to the emergency department (ED). Sensitivity and specificity of different cutoff value were calculated. Best cutoff value will be decided by the perfomance.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Chang Gung Memorial Hospital, Linkou Medical Center
🇨🇳Taoyuan, 新北市, Taiwan